back to homepage

Uncategorized

SY Holdings Announces 2023 Interim Results – Digital Technology Empowers Inclusive Finance and Platform-Based Services Boost Common Prosperity in the Enterprise Ecosystem

Hong Kong – SY Holdings Group Limited (“SY” or the “Group” or the “Company”, stock code: 6069.HK) announced its interim results for the six months ended 30 June 2023 (the

Read More

Revive Lighting Announces Annual Reservation Period for Expert Christmas Light Installation in Surrey, BC

Christmas Light Installation in Surrey, BC – Revive Lighting – Christmas Light Installation Surrey. Revive Lighting – Christmas Light Installation Surrey provides residential & commercial Christmas Light Installation. They provide

Read More

Cloud Chain World Finance LTD Hosts 2023 Finance Forum in London, Focusing on Innovation and Cooperation in Internet Finance

Cloud Chain World Finance LTD, a company dedicated to building the world’s leading Internet finance platform, recently held the 2023 Finance Forum at the Royal Albert Hall in London, inviting

Read More

Chronic Hepatitis B Virus Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Ligand Pharma, Dicerna, Vir Biotechnology, Roche

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 50+ key pharma and biotech companies are working on 55+ pipeline drugs in the Chronic Hepatitis B Virus therapeutics landscape

Read More

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-32) – DelveInsight | Immunogen, Cellectis S.A, MustangBio, Xencor

Delveinsight Business Research LLP As per DelveInsight, the Blastic Plasmacytoid Dendritic Cell Neoplasm Market is anticipated to evolve immensely in the coming years owing to the rise in the number

Read More

Chemotherapy-Induced Diarrhea (CID) Market to Register Incremental Growth During the Forecast Period (2023-2032) – DelveInsight | Key Players – Napo Pharmaceuticals/Jaguar Health MYTESI (crofelemer)

Delveinsight Business Research LLP As per DelveInsight, the Chemotherapy-Induced Diarrhea Market is anticipated to evolve immensely in the coming years owing to the already prescribed products along with the launch

Read More

Hemophilia B Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Alnylam, ApcinteX, Bioverativ, CSL Behring, Genzyme, HEMA Biologics, UniQure, Sangamo

Delveinsight Business Research LLP As per DelveInsight, the Hemophilia B Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases of

Read More

HER2-Negative Breast Cancer Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | AstraZeneca, Laekna, Novartis, Roche, Eli Lilly

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 85+ key pharma and biotech companies are working on 85+ pipeline drugs in the HER2-Negative Breast Cancer therapeutics landscape based

Read More

Idiopathic Pulmonary Fibrosis (IPF) Market Poised for Phenomenal Growth During the Forecast Period (2023-32) – DelveInsight | Biogen, Celgene, Roche, Galapagos NV, FibroGen, MediciNova, Novartis

Delveinsight Business Research LLP The Idiopathic Pulmonary Fibrosis Market size in seven major markets was USD 3,167 million in 2021, which is further expected to increase by 2032 at a

Read More

Acute Myeloid Leukemia (AML) Market Set to Experience Unprecedented Growth During the Forecast Period (2023-32) – DelveInsight | Gamida Cell, GlycoMimetics, ImmunityBio, Bellicum Pharmaceuticals

Delveinsight Business Research LLP As per DelveInsight, the Acute Myeloid Leukemia Market is anticipated to evolve immensely in the coming years owing to the rise in the number of cases

Read More